WELL reports this morning having entered the session with a subtle but meaningful change in options positioning — the bullish tilt that defined the run-up has moderated, even as the stock holds near record levels.
The most notable development since the prior earnings preview is the put/call ratio. It edged back up to 0.76 on Monday's close, still roughly two and a half standard deviations below its 20-day average of 0.92, but no longer at the extreme call-dominated readings of 0.71–0.74 seen earlier in the week. Call buyers remain in control — but less aggressively so. The stock itself gave back 1.5% on Monday to close at $248.34, a minor pullback after a 9% monthly gain. The borrow market offers no drama whatsoever: availability runs above 3,500% of short interest, cost to borrow has eased nearly 20% over the past month to just 0.42%, and short interest at 2.7% of the float is low and essentially flat over the week. There is no meaningful short-side pressure here.
The analyst picture remains broadly constructive, with an important caveat. Most of the Street is bullish — UBS at $271, Deutsche Bank at $265, Mizuho at $260 — but the consensus mean of roughly $245 now trails the stock price of $248. WELL has run past the midpoint of analyst targets. Barclays, which initiated at Equal-Weight with a $254 target on July 7, sits closest to the current price and best captures the tension: the bull case rests on a 2,391-property portfolio, strong Canadian operations, and what the company has projected as 30% revenue growth for FY24. The bear case focuses on integration risk from acquisitions, a reported EBITDA miss, and a valuation that has become genuinely stretched — the PE ratio has expanded roughly nine points over the past month to nearly 79x, and EV/EBITDA runs above 33x. The ORTEX momentum score remains exceptional at 89.7, but value ranks near zero. Those two readings rarely coexist comfortably for long.
Peer performance on Monday underscores WELL's relative softness heading into the print. VTR gained 2.7% on the day and SBRA added 1.5%, while OHI, AHR and CTRE all closed higher. WELL was the only major healthcare REIT in the red. That divergence — sector buying while the sector leader dips — is consistent with a market rotating into cheaper names on the eve of the result.
Today's print will test whether the operational momentum that drove a 36% year-to-date rally can be backed by numbers that justify trading above consensus targets at 33x EBITDA.
See the live data behind this article on ORTEX.
Open WELL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
